NCT04941001View on ClinicalTrials.gov

Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS)

NACompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

August 9, 2021

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
AsthmaAsthma AttackAsthma PersistentCovid19
Interventions
DEVICE

ReferID

The ReferID tool is a digital tool which can be used to facilitate a review of asthma in primary care

Trial Locations (1)

SE1 9RT

Guys and St Thomas NHS Foundation Trust, London

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

King's College London

OTHER

lead

Guy's and St Thomas' NHS Foundation Trust

OTHER